Get started
Bristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 ShBristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 ShBristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 Sh

Bristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 Sh

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

BMY chart


Full chart

Key stats


Market capitalization
‪131.72 T‬ ARS
Dividend yield (indicated)
3.28%
Price to earnings Ratio (TTM)
25
Basic EPS (TTM)
875 ARS
Net income (FY)
‪−8.19 T‬ ARS
Revenue (FY)
‪44.23 T‬ ARS
Shares float
—
Beta (1Y)
0.02

About Bristol-Myers Squibb Company


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Christopher S. Boerner
Website
bms.com
Headquarters
Princeton
Founded
1933
ISIN
ARDEUT112877
FIGI
BBG000L7BMZ1
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Check out other big names from the same industry as BMY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BMY news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

BMY highest yielding bonds


BMY.GB
Bristol-Myers Squibb Company 6.8% 15-NOV-2026
Yield to maturity
—
Maturity date
Nov 15, 2026
C
BMY4597873
Celgene Corporation 3.9% 20-FEB-2028
Yield to maturity
—
Maturity date
Feb 20, 2028
BMY4831824
Bristol-Myers Squibb Company 3.4% 26-JUL-2029
Yield to maturity
—
Maturity date
Jul 26, 2029
BMY5754772
Bristol-Myers Squibb Company FRN 20-FEB-2026
Yield to maturity
—
Maturity date
Feb 20, 2026
C
BMY4560589
Celgene Corporation 4.35% 15-NOV-2047
Yield to maturity
—
Maturity date
Nov 15, 2047
BMY4931963
Bristol-Myers Squibb Company 4.55% 20-FEB-2048
Yield to maturity
—
Maturity date
Feb 20, 2048
BMY5077466
Bristol-Myers Squibb Company 0.75% 13-NOV-2025
Yield to maturity
—
Maturity date
Nov 13, 2025
BMY4926518
Bristol-Myers Squibb Company 3.45% 15-NOV-2027
Yield to maturity
—
Maturity date
Nov 15, 2027
BMY4831822
Bristol-Myers Squibb Company 3.2% 15-JUN-2026
Yield to maturity
—
Maturity date
Jun 15, 2026
C
BMY4036425
Celgene Corporation 5.25% 15-AUG-2043
Yield to maturity
—
Maturity date
Aug 15, 2043
BMY5007349
Bristol-Myers Squibb Company 5.25% 15-AUG-2043
Yield to maturity
—
Maturity date
Aug 15, 2043

See all BMY bonds 

Sparks


Curated watchlists where BMY is featured.

See all sparks